News
Dabigatran, rivaroxaban linked to slight increase in GI bleeding risk
October 2, 2017
Overall, the risk of major bleeds associated with NOACs was similar to the risk with conventional anticoagulants.
![1]()
News
No benefit seen for routine low-dose oxygen after stroke
September 26, 2017
The large SO2S trial found no benefit for continuous or night-only routine oxygen supplementation.
News
How to manage bleeding in patients taking direct oral anticoagulants (DOACs)
September 21, 2017
As a primary concern about the routine use of direct oral anticoagulants has been the lack of commercially available direct reversal agents, clinicians are often left wondering how to manage bleeding episodes in patients receiving DOACs.
![1]()
News
While U.S. heart failure readmissions fall, deaths rise
September 20, 2017
DALLAS – CMS’s penalties for heart failure outcomes may have unintentionally pushed hospitals toward “gaming the system.”
News
Sneak Peek: Journal of Hospital Medicine – Sept. 2017
September 20, 2017
Read the latest research from the Journal of Hospital Medicine, the premier publication for dissemination of research and education for the specialty of hospital medicine.
![1]()
News
VIDEO: Educational intervention boosts A fib anticoagulation
September 19, 2017
BARCELONA – Patient education and feedback increased anticoagulation and cut strokes.
![1]()
News
Statins linked to lower death rates in COPD
September 19, 2017
Researchers explore whether COPD progression results from systemic inflammation.
![1]()
Video
VIDEO: What’s new in AAP’s pediatric hypertension guidelines
September 15, 2017
SAN FRANCISCO – Some of the advice is similar to the group’s last effort in 2004, but there are a few key changes.
![1]()
Opinion
Hospital value-based purchasing is largely ineffective
September 7, 2017
Complicated pay-for-performance programs divert limited available resources away from meaningful improvement activities in order to comply with onerous reporting requirements.
![1]()
News
Ivabradine cut mortality in HFrEF patients not on beta-blocker
September 7, 2017
BARCELONA – Secondary analysis of SHIFT trial suggests potential expanded role for heart failure agent.
